About Chembio
Chembio is a company based in Medford (United States) founded in 1986 was acquired by Biosynex in January 2023.. The company has 213 employees as of December 31, 2022. Chembio has completed 1 acquisition, including Orangelife Comercio E Industria. Chembio offers products and services including DPP HIV-Syphilis Assay, DPP HIV 1/2 Assay, SURE CHECK HIV Self-Test, DPP Zika IgM/IgG System, and Advin COVID-19 Antigen Test. Chembio operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, Quantalife, Senzo and Hememics Biotechnologies, among others.
- Headquarter Medford, United States
- Employees 213 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Chembio Diagnostics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chembio
Chembio offers a comprehensive portfolio of products and services, including DPP HIV-Syphilis Assay, DPP HIV 1/2 Assay, SURE CHECK HIV Self-Test, DPP Zika IgM/IgG System, and Advin COVID-19 Antigen Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid test for detecting HIV and syphilis in blood samples.
Assay for identifying HIV types 1 and 2 quickly and accurately.
Home-based test kit for HIV detection with easy user instructions.
System for detecting Zika virus antibodies in clinical settings.
Antigen test for rapid COVID-19 detection at home or point-of-care.
Unlock access to complete
Funding Insights of Chembio
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $20.0M
-
First Round
First Round
(01 Jun 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Debt – Conventional - Chembio | Valuation |
investors |
|
| Feb, 2011 | Amount | Grant - Chembio | Valuation |
investors |
|
| Jun, 2009 | Amount | Grant - Chembio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chembio
Chembio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Biosynex and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Professional rapid diagnostic tests for diseases are manufactured by Biosynex.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chembio
Chembio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orangelife Comercio E Industria. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostic test kits are manufactured for healthcare applications.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Chembio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chembio Comparisons
Competitors of Chembio
Chembio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, Quantalife, Senzo and Hememics Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopreservation platform for mammalian cells and biologics is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chembio
Frequently Asked Questions about Chembio
When was Chembio founded?
Chembio was founded in 1986 and raised its 1st funding round 21 years after it was founded.
Where is Chembio located?
Chembio is headquartered in Medford, United States. It is registered at Medford, Oregon, United States.
Who is the current CEO of Chembio?
Richard Eberly is the current CEO of Chembio.
How many employees does Chembio have?
As of Dec 31, 2022, the latest employee count at Chembio is 213.
What is the annual revenue of Chembio?
Annual revenue of Chembio is $49.52M as on Dec 31, 2022.
What does Chembio do?
Chembio Diagnostics, Inc. was established in 1986 in Medford, United States, within the medical diagnostics sector. Rapid tests for infectious diseases, including two FDA PMA-approved, CLIA-waived HIV assays, are produced using the patented Dual Path Platform technology. In the U.S., these HIV tests are distributed by Alere, Inc. Internationally, the HIV STAT-PAK line is supplied to government and donor-funded programs through direct sales and distributors.
Who are the top competitors of Chembio?
Chembio's top competitors include Souzhou Ribo Life Science, Quantalife and Senzo.
What products or services does Chembio offer?
Chembio offers DPP HIV-Syphilis Assay, DPP HIV 1/2 Assay, SURE CHECK HIV Self-Test, DPP Zika IgM/IgG System, and Advin COVID-19 Antigen Test.
How many acquisitions has Chembio made?
Chembio has made 1 acquisition, including Orangelife Comercio E Industria.
Who are Chembio's investors?
Chembio has 3 investors. Key investors include HHS, Biosynex, and Perceptive Advisors.